Literature DB >> 11142830

[Pregnancy outcome in women infected with the human immunodeficiency virus].

R Figueroa-Damián1.   

Abstract

OBJECTIVE: To identify the medical complications in a cohort of HIV-infected, pregnant women and to determine the risk of having the virus in the development of these complications.
MATERIAL AND METHODS: A cohort study of 44 HIV-infected and 88 seronegative pregnant women was performed. Pregnancy was followed and perinatal results were compared. HIV-infected women were asymptomatic with CD4 count > 200 mm3. Patients were matched for age and socioeconomic status.
RESULTS: In 42 (95.4%) of HIV patients the disease had been transmitted sexually; 35 (79.5%) had been infected for less than one year and 15 (34%) received antiviral treatment during pregnancy. HIV-infected patients showed greater risk of infectious disorders (RR3.1, CI95% 1.9-52), cervical infections (RR 2.2, CI95% 1-48) and sexually transmitted diseases (RR 18, CI95% 2.3-137). Newborns showed low birth weight and were premature, and neonatal affections were similar in the two groups compared. Stratified analysis showed that no antiretroviral treatment and more than three sexual partners increase the risk of infections.
CONCLUSIONS: HIV-seropositive, asymptomatic, pregnant women with > 200/mm3 CD4 count did not show greater medical risk along pregnancy and birth, although higher incidence of infections was detected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11142830

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

Review 1.  The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis.

Authors:  Clara Calvert; Carine Ronsmans
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

Review 2.  HIV and the risk of direct obstetric complications: a systematic review and meta-analysis.

Authors:  Clara Calvert; Carine Ronsmans
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.